- Published at
- by investing.com
negative
negative
FDA FAST TRACK DESIGNATION FOR NARMAFOTINIB IN ADVANCED PANCREATIC CANCER By Investing.com
FDA FAST TRACK DESIGNATION FOR NARMAFOTINIB IN ADVANCED PANCREATIC CANCER
News for Amplia Therapeutics Limited (INNMF)
- Published at
- by prnewswire.com
negativenegativeAMP945 Combined with FOLFIRINOX Enhances Treatment Effects in model of Pancreatic Cancer
HIGHLIGHTS Amplia's highly selective FAK inhibitor AMP945, when used in combination with FOLFIRINOX, enhances survival in a preclinical model of pancreatic...- Published at
- by prnewswire.com
mixedmixedPropulsion of Pancreatic Cancer Pipeline as Novel and Extensive 170+ Therapies Likely to Enter in the Treatment Domain | DelveInsight
/PRNewswire/ -- DelveInsight's 'Pancreatic Cancer Pipeline Insight – 2022' report provides comprehensive global coverage of available, marketed, and pipeline...- Published at
- by globenewswire.com
mixedmixedNew Therapeutics Options in Pancreatic Ductal Adenocarcinoma Pipeline as 40+ Key Companies are Working on Drug Profiles | DelveInsight
DelveInsight’s pancreatic ductal adenocarcinoma pipeline report depicts a robust space with 40+ active players working to develop 50+ pipeline therapies...- Published at
- by etfdailynews.com
positivepositiveWarwick Tong Purchases 161,107 Shares of Amplia Therapeutics Limited (ASX:ATX) Stock
Read Warwick Tong Purchases 161,107 Shares of Amplia Therapeutics Limited (ASX:ATX) Stock at ETF Daily News- Published at
- by stockhead.com.au
mixedmixedClosing Bell: Mrs Pelosi goes to Taipei; Pfizer comes back for ResApp
ASX 200 is down, small caps surge late. Tech and consumer stocks lift while energy drags. Chinese markets higher on Pelosi goes to Taipei day.TMXXFTMRFFTMR.AXSGPLFRCELGLV.AXCLE.AXCBE.AXBRYYFBAKPFAVHHLAVH.AXASXFYASXFFARU.AXARAFFANL.AXAL3.AXZNC.AXZMM.AXUREQFTMX.AXRAP.AXQFY.AXPKO.AXORI.AXOCLDYOCLDFNGY.AXMRR.AXMMM.AXMLYSFMEB.AXMDBIFM8S.AXIXRRFIXR.AXIPDQFIPD.AXINNMFHFY.AXFRM.AXFRGYFGL.AXDEV.AXBTRYFBAT.AXATX.AXASP.AXADS.AXVOL.AXTISNFCAV.AXADXRF- Published at
- by marketscreener.com
neutralneutralAmplia Therapeutics : Quarterly Activities and Cashflow Reports - Dec 2021 Qtr
For personal use only ASX RELEASE ... | January 23, 2022- Published at
- by marketscreener.com
positivepositiveAmplia Therapeutics : Update - Application for quotation of securities - ATX
Application for quotation of +securities Update Summary For personal use only ... | December 19, 2021- Published at
- by marketscreener.com
positivepositiveAmplia Therapeutics : Provides Updated Investor Presentation
For personal use only ABN 16 165 160 841 ... | December 15, 2021- Published at
- by stockhead.com.au
mixedmixedASX Capital Raise Roundup: Tight, tight, tight!
In summation, we could be setting up for a case of low expectations plus strong earnings reports which would lead to higher share prices.